Human serum transferrin glycosylation pattern : population differences, analytical methodology and application as a biomarker for testing of alcohol abuse and CDG
Author: Bergström, Jonas P
Date: 2007-12-07
Location: Magnus Huss aula
Time: 09.00
Department: Institutionen för klinisk neurovetenskap / Department of Clinical Neuroscience
View/ Open:
Thesis (585.8Kb)
Abstract
Alcohol use and abuse is a major social and economic problem in many
societies. Carbohydrate-deficient transferrin (CDT) is a widely used and
highly specific biochemical alcohol marker of prolonged alcohol abuse.
Increased knowledge about the clinical characteristics of CDT may lead to
better possibilities of employing CDT as a biochemical alcohol marker of
risky and heavy alcohol consumption and thus creating better
opportunities for prevention and intervention of alcohol dependence. The
aim of this thesis was to contribute to this knowledge by investigating
the properties of CDT in different populations and evaluating the
sensitivity and specificity of different analytical methodologies for
analysis of CDT.
Serum samples (n=1387) from subjects originating from five different countries were analyzed with a HPLC candidate reference method for CDT. In non-drinkers there were minimal differences in the serum transferrin glycoform pattern with respect to different ethnicity, gender, age and BMI. When evaluating disialotransferrin, the primary glycoform in CDT, with respect to the same categories, no clinically significant differences were detected. Furthermore the overall test accuracy for identification of heavy drinkers (>210 g ethanol/week for men and >140 g ethanol/week for women) showed no gender difference.
Serum samples (n=178) were analyzed from subjects with clinical or pharmacological factors previously reported to cause false-positive CDT levels. Only ~5% showed a relative disialotransferrin level exceeding the upper limit for the reference interval, leading to a conclusion that earlier reports on reasons for false positive CDT values are linked with the methodology used rather than with true physiological influences.
When compared with a HPLC candidate reference method, the Bio-Rad %CDT HPLC test and the CEofix CDT assay proved to be appropriate for confirmatory and routine %CDT testing, showing an overall good correlation and agreement. The HPLC candidate reference method could readily be used for preliminary diagnosis of CDG and for assignment of cases to either CDG-I or CDG-II.
Serum samples (n=1387) from subjects originating from five different countries were analyzed with a HPLC candidate reference method for CDT. In non-drinkers there were minimal differences in the serum transferrin glycoform pattern with respect to different ethnicity, gender, age and BMI. When evaluating disialotransferrin, the primary glycoform in CDT, with respect to the same categories, no clinically significant differences were detected. Furthermore the overall test accuracy for identification of heavy drinkers (>210 g ethanol/week for men and >140 g ethanol/week for women) showed no gender difference.
Serum samples (n=178) were analyzed from subjects with clinical or pharmacological factors previously reported to cause false-positive CDT levels. Only ~5% showed a relative disialotransferrin level exceeding the upper limit for the reference interval, leading to a conclusion that earlier reports on reasons for false positive CDT values are linked with the methodology used rather than with true physiological influences.
When compared with a HPLC candidate reference method, the Bio-Rad %CDT HPLC test and the CEofix CDT assay proved to be appropriate for confirmatory and routine %CDT testing, showing an overall good correlation and agreement. The HPLC candidate reference method could readily be used for preliminary diagnosis of CDG and for assignment of cases to either CDG-I or CDG-II.
List of papers:
I. Bergström JP, Helander A (2007). "Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: Implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker." Clin Chim Acta Oct 13: Epub ahead of print
Pubmed
II. Bergström JP, Helander A (2007). "Clinical characteristics of carbohydrate-deficient transferrin (CDT) measured by HPLC: sensitivity, specificity, gender differences and relationship with other markers of prolonged alcohol abuse." (Submitted)
III. Bergström JP, Helander A (2007). "HPLC evaluation of clinical and pharmacological factors reported to cause false-positive carbohydrate-deficient transferrin (CDT) levels." (Submitted)
IV. Helander A, Bergström JP (2006). "Determination of carbohydrate-deficient transferrin in human serum using the Bio-Rad %CDT by HPLC test." Clin Chim Acta 371(1-2): 187-90. Epub 2006 May 15
Pubmed
V. Helander A, Wielders JP, Te Stroet R, Bergström JP (2005). "Comparison of HPLC and capillary electrophoresis for confirmatory testing of the alcohol misuse marker carbohydrate-deficient transferrin." Clin Chem 51(8): 1528-31
Pubmed
VI. Helander A, Bergström J, Freeze HH (2004). "Testing for congenital disorders of glycosylation by HPLC measurement of serum transferrin glycoforms. " Clin Chem 50(5): 954-8
Pubmed
I. Bergström JP, Helander A (2007). "Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: Implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker." Clin Chim Acta Oct 13: Epub ahead of print
Pubmed
II. Bergström JP, Helander A (2007). "Clinical characteristics of carbohydrate-deficient transferrin (CDT) measured by HPLC: sensitivity, specificity, gender differences and relationship with other markers of prolonged alcohol abuse." (Submitted)
III. Bergström JP, Helander A (2007). "HPLC evaluation of clinical and pharmacological factors reported to cause false-positive carbohydrate-deficient transferrin (CDT) levels." (Submitted)
IV. Helander A, Bergström JP (2006). "Determination of carbohydrate-deficient transferrin in human serum using the Bio-Rad %CDT by HPLC test." Clin Chim Acta 371(1-2): 187-90. Epub 2006 May 15
Pubmed
V. Helander A, Wielders JP, Te Stroet R, Bergström JP (2005). "Comparison of HPLC and capillary electrophoresis for confirmatory testing of the alcohol misuse marker carbohydrate-deficient transferrin." Clin Chem 51(8): 1528-31
Pubmed
VI. Helander A, Bergström J, Freeze HH (2004). "Testing for congenital disorders of glycosylation by HPLC measurement of serum transferrin glycoforms. " Clin Chem 50(5): 954-8
Pubmed
Issue date: 2007-11-16
Rights:
Publication year: 2007
ISBN: 978-91-7357-432-7
Statistics
Total Visits
Views | |
---|---|
Human ...(legacy) | 1064 |
Human ... | 275 |
Total Visits Per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Human ... | 3 | 1 | 0 | 5 | 2 | 0 | 0 |
File Visits
Views | |
---|---|
thesis.pdf(legacy) | 595 |
thesis.pdf | 246 |
thesis.pdf.txt(legacy) | 2 |
Top country views
Views | |
---|---|
United States | 462 |
Sweden | 129 |
Ukraine | 90 |
China | 65 |
Germany | 65 |
United Kingdom | 30 |
Slovakia | 29 |
South Korea | 26 |
Finland | 25 |
Croatia | 17 |
Top cities views
Views | |
---|---|
Sunnyvale | 36 |
Romeo | 31 |
Stockholm | 29 |
Beijing | 23 |
Seoul | 20 |
Helsinki | 17 |
Kiez | 17 |
Bratislava | 11 |
Zagreb | 11 |
Dublin | 10 |